November, 09. 2018

CRU-286 Internal Meeting RP8 - Michal-Ruth Schweiger

Further information

October, 04. 2018

34th Ernst Klenk Symposium in Molecular Medicine Announcement - Invitation

Further information

September, 07. 2018

CRU-286 Internal Meeting RP7 - Lukas Frenzel

Further information

July, 11. 2018

Cologne Cancer Club Speaker: Davide Rossi, MD, Experimental Hematology Institute of Oncology Research, Bellinzona, Switzerland

Title: “Circulating tumor DNA in B-cell malignancies”

July, 05. 2018

CRU-286 Internal Meeting RP6 - Michael Hallek

Further information

May, 17. 2018

CRU-286 Internal Meeting RP5 - Thomas Wunderlich/ Christian Pallasch

Further information

April, 24. 2018

Cologne Cancer Club Speaker: Dan G. Duda, DMD, PhD, Director of Translational Research in GI Radiation Oncology, Massachusetts General Hospital and Associate Professor of Tumor Biology at Harvard Medical School

Title: “Using biomarkers to guide antiangiogenic, radiation and immuno-therapies for GI cancers”

April, 13. 2018

CRU-286 Internal Meeting RP3 - Hamid Kashkar/ Thorsten Hoppe

Further information

March, 16. 2018

CRU-286 Internal Meeting RP2 - Christian Reinhardt

Further information

February, 01. 2018

1st Cologne Symposium on DLBCL A focused mini symposium on DLBCL biology, mouse models and genotype-stratified therapeutic approaches

High-risk CLL remains a clinical challenge, even in the era of the novel targeted agents, such as ibrutinib, venetoclax and idelalisib. Particularly Richter transformation, which is a common presentation of relapsed disease after targeted therapy, remains very difficult to treat. In the second funding period of the KFO-286, we began to focus our efforts on characterizing high-risk CLL, as well as the discovery of molecular mechanisms of drug resistance and transformation. To further engage with the scientific community working on aggressive lymphomas and transformed disease, we organized the Cologne DLBCL Symposium. The first meeting takes place on February 1st in the new lecture hall of the Max Planck Institute for Aging Research in Cologne. We have assembled an illustrious list of confirmed speakers, as well as numerous poster presentations (Download Programme here).  The symposium is organized and co-funded by the KFO-286 (led by M. Hallek and C. Reinhardt) and the Center for Integrated Oncology Cologne-Bonn (CIO, speaker M. Hallek).